A
Avadel Pharmaceuticals - ADR (AVDL)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Avadel Pharmaceuticals - ADR (AVDL)
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcole... Read more
- USD11.08
- USD11.40
- USD11.05
- USD16.85
- -20.30%
- 1M
- 211.03k
- 473.82k
- 1.0B
- 4.70
- 129.90%
Stock News
1 hour ago
Dow Jones Futures: Market Correction Intensifies, S&P 500 Nears Key Level; Meta AI Push In Focus
Yahoo
1 hour ago
: Fed rate cuts could come sooner than expected, says former Goldman CEO Lloyd Blankfein
MarketWatch
yesterday
The Ratings Game: Could a break-up of Amazon be good for the stock? Analysts weigh in after FTC lawsuit.
MarketWatch
yesterday
Cramer says Amazon and Google stocks are still buys, despite antitrust lawsuits
CNBC
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
